Aspen Aerogels (ASPN) Misses Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts ASPN Hot Sheet
Price: $4.93 --0%
Revenue Growth %: -4.4%
Financial Fact:
Income Tax (Expense) Benefit: 1.25M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -4.4%
Financial Fact:
Income Tax (Expense) Benefit: 1.25M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $48 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Summit Therapeutics plc (SMMT) Reiterated at Overweight by Cantor Fitzgerald
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
